Alzamend Neuro is trading at $1.33, up 5.56% in after-hours trading, with no verified company-specific announcement dated October 15 explaining the move.
- It closed the regular session at $1.26 on October 15, per the supplied price context.
- Its investor-relations page lists September 16 as the latest release, about regaining Nasdaq listing compliance.
- The broader market was mixed, and reviewed sources did not establish a market-wide cause. After-hours volume details were unavailable.